Literature DB >> 31358659

Immune Response Resetting in Ongoing Sepsis.

Alexandre E Nowill1, Márcia C Fornazin2, Maria C Spago2, Vicente Dorgan Neto3, Vitória R P Pinheiro2, Simônia S S Alexandre1, Edgar O Moraes4, Gustavo H M F Souza5, Marcos N Eberlin4, Lygia A Marques6, Eduardo C Meurer6, Gilberto C Franchi2, Pedro O de Campos-Lima7.   

Abstract

Cure of severe infections, sepsis, and septic shock with antimicrobial drugs is a challenge because morbidity and mortality in these conditions are essentially caused by improper immune response. We have tested the hypothesis that repeated reactivation of established memory to pathogens may reset unfavorable immune responses. We have chosen for this purpose a highly stringent mouse model of polymicrobial sepsis by cecum ligation and puncture. Five weeks after priming with a diverse Ag pool, high-grade sepsis was induced in C57BL/6j mice that was lethal in 24 h if left untreated. Antimicrobial drug (imipenem) alone rescued 9.7% of the animals from death, but >5-fold higher cure rate could be achieved by combining imipenem and two rechallenges with the Ag pool (p < 0.0001). Antigenic stimulation fine-tuned the immune response in sepsis by contracting the total CD3+ T cell compartment in the spleen and disengaging the hyperactivation state in the memory T subsets, most notably CD8+ T cells, while preserving the recovery of naive subsets. Quantitative proteomics/lipidomics analyses revealed that the combined treatment reverted the molecular signature of sepsis for cytokine storm, and deregulated inflammatory reaction and proapoptotic environment, as well as the lysophosphatidylcholine/phosphatidylcholine ratio. Our results showed the feasibility of resetting uncontrolled hyperinflammatory reactions into ordered hypoinflammatory responses by memory reactivation, thereby reducing morbidity and mortality in antibiotic-treated sepsis. This beneficial effect was not dependent on the generation of a pathogen-driven immune response itself but rather on the reactivation of memory to a diverse Ag pool that modulates the ongoing response.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Year:  2019        PMID: 31358659      PMCID: PMC6697741          DOI: 10.4049/jimmunol.1900104

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  122 in total

1.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

2.  Role of nitric oxide in the failure of neutrophil migration in sepsis.

Authors:  C F Benjamim; S H Ferreira; F Q Cunha
Journal:  J Infect Dis       Date:  2000-06-29       Impact factor: 5.226

3.  The danger model: a renewed sense of self.

Authors:  Polly Matzinger
Journal:  Science       Date:  2002-04-12       Impact factor: 47.728

Review 4.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 5.  On differences between immunity and immunological memory.

Authors:  Rolf M Zinkernagel
Journal:  Curr Opin Immunol       Date:  2002-08       Impact factor: 7.486

6.  Enzyme-friendly, mass spectrometry-compatible surfactant for in-solution enzymatic digestion of proteins.

Authors:  Ying-Qing Yu; Martin Gilar; Peter J Lee; Edouard S P Bouvier; John C Gebler
Journal:  Anal Chem       Date:  2003-11-01       Impact factor: 6.986

7.  Early antibiotic administration but not antibody therapy directed against IL-6 improves survival in septic mice predicted to die on basis of high IL-6 levels.

Authors:  Dinesh Vyas; Pardis Javadi; Peter J Dipasco; Timothy G Buchman; Richard S Hotchkiss; Craig M Coopersmith
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-06-09       Impact factor: 3.619

8.  Interleukin 10 extends the effectiveness of standard therapy during late sepsis with serum interleukin 6 levels predicting outcome.

Authors:  Mollie O Manley; Mary Ann O'Riordan; Alan D Levine; Samir Q Latifi
Journal:  Shock       Date:  2005-06       Impact factor: 3.454

9.  Therapeutic effects of lysophosphatidylcholine in experimental sepsis.

Authors:  Ji-Jing Yan; Jun-Sub Jung; Jung-Eun Lee; Jongho Lee; Sung-Oh Huh; Hee-Sung Kim; Kyeong Cheon Jung; Jae-Young Cho; Ju-Suk Nam; Hong-Won Suh; Yung-Hi Kim; Dong-Keun Song
Journal:  Nat Med       Date:  2004-01-11       Impact factor: 53.440

10.  Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients.

Authors:  Wolfgang Drobnik; Gerhard Liebisch; Franz-Xaver Audebert; Dieter Frohlich; Thomas Gluck; Peter Vogel; Gregor Rothe; Gerd Schmitz
Journal:  J Lipid Res       Date:  2003-01-16       Impact factor: 5.922

View more
  11 in total

1.  Up-regulation of TUG1 can regulate miR-494/PDK4 axis to inhibit LPS-induced acute lung injury caused by sepsis.

Authors:  Lin Yang; Li Zhao; Hui Zhang; Peili Chen
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

2.  Enhanced IL-10 inhibits proliferation and promotes apoptosis of HUVECs through STAT3 signaling pathway in sepsis.

Authors:  Zuohua Xie; Bing Lin; Xinju Jia; Ting Su; Ying Wei; Jiping Tang; Chengzhi Yang; Chuanbao Cui; Jinxiang Liu
Journal:  Histol Histopathol       Date:  2021-09-16       Impact factor: 2.303

Review 3.  Challenging molecular dogmas in human sepsis using mathematical reasoning.

Authors:  Peter Ghazal; Patricia R S Rodrigues; Mallinath Chakraborty; Siva Oruganti; Thomas E Woolley
Journal:  EBioMedicine       Date:  2022-05-03       Impact factor: 11.205

Review 4.  Persistence of Lipoproteins and Cholesterol Alterations after Sepsis: Implication for Atherosclerosis Progression.

Authors:  Krzysztof Laudanski
Journal:  Int J Mol Sci       Date:  2021-09-29       Impact factor: 6.208

5.  Long-Term Abnormalities of Lipid Profile After a Single Episode of Sepsis.

Authors:  Nicholas Felici; Da Liu; Josh Maret; Mariana Restrepo; Yuliya Borovskiy; Jihane Hajj; Wesley Chung; Krzysztof Laudanski
Journal:  Front Cardiovasc Med       Date:  2021-11-15

6.  High-Fat Diet-Induced Fatty Liver Is Associated with Immunosuppressive Response during Sepsis in Mice.

Authors:  Fangzhao Wang; Zhongran Cen; Zhanguo Liu; Jianwei Gan; Xianglong Zhang; Qianru Cui; Shenhai Gong; Ping Chang; Peng Chen
Journal:  Oxid Med Cell Longev       Date:  2021-12-08       Impact factor: 6.543

Review 7.  Of mice and men: Laboratory murine models for recapitulating the immunosuppression of human sepsis.

Authors:  Ning Wang; Yongling Lu; Jiang Zheng; Xin Liu
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

8.  TREML4 receptor regulates inflammation and innate immune cell death during polymicrobial sepsis.

Authors:  Christina Nedeva; Joseph Menassa; Mubing Duan; Chuanxin Liu; Marcel Doerflinger; Andrew J Kueh; Marco J Herold; Pamali Fonseka; Thanh Kha Phan; Pierre Faou; Harinda Rajapaksha; Weisan Chen; Mark D Hulett; Hamsa Puthalakath
Journal:  Nat Immunol       Date:  2020-10-05       Impact factor: 25.606

Review 9.  CD4 T Cell Responses and the Sepsis-Induced Immunoparalysis State.

Authors:  Matthew D Martin; Vladimir P Badovinac; Thomas S Griffith
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

10.  Effective delivery of mycophenolic acid by oxygen nanobubbles for modulating immunosuppression.

Authors:  Muhammad Saad Khan; Jae-Sung Kim; Jangsun Hwang; Yonghyun Choi; Kyungwoo Lee; Yejin Kwon; Jaehee Jang; Semi Yoon; Chul-Su Yang; Jonghoon Choi
Journal:  Theranostics       Date:  2020-03-04       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.